Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 9783563)

1.

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

Fallon BA, Liebowitz MR, Campeas R, Schneier FR, Marshall R, Davies S, Goetz D, Klein DF.

Arch Gen Psychiatry. 1998 Oct;55(10):918-24.

PMID:
9783563
2.

Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.

Koran LM, Sallee FR, Pallanti S.

Am J Psychiatry. 1997 Mar;154(3):396-401.

PMID:
9054789
3.

Open trial of intravenous clomipramine in five treatment-refractory patients with obsessive-compulsive disorder.

Fallon BA, Campeas R, Schneier FR, Hollander E, Feerick J, Hatterer J, Goetz D, Davies S, Liebowitz MR.

J Neuropsychiatry Clin Neurosci. 1992 Winter;4(1):70-5.

PMID:
1627966
4.
5.

Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison.

Koran LM, McElroy SL, Davidson JR, Rasmussen SA, Hollander E, Jenike MA.

J Clin Psychopharmacol. 1996 Apr;16(2):121-9.

PMID:
8690827
6.

Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.

Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.

J Clin Psychiatry. 1994 Jul;55(7):301-5.

PMID:
8071291
7.

Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.

Pallanti S, Quercioli L, Koran LM.

J Clin Psychiatry. 2002 Sep;63(9):796-801.

PMID:
12363120
8.
9.

Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder.

Koran LM, Aboujaoude E, Ward H, Shapira NA, Sallee FR, Gamel N, Elliott M.

J Clin Psychopharmacol. 2006 Feb;26(1):79-83.

PMID:
16415712
10.

Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.

Hoehn-Saric R, McLeod DR, Zimmerli WD, Hipsley PA.

J Clin Psychiatry. 1993 Jul;54(7):272-6.

PMID:
8335655
11.

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.

McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH.

Arch Gen Psychiatry. 1994 Apr;51(4):302-8.

PMID:
8161290
12.
13.
14.
15.

Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.

Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.

J Clin Psychiatry. 1990 Jul;51(7):292-7.

PMID:
2195006
16.

Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder.

Mathew SJ, Coplan JD, Perko KA, Goetz RR, de la Neuz M, Hollander E, Liebowitz MR, Fallon BA.

Depress Anxiety. 2001;14(4):199-208.

PMID:
11754126
17.

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial.

Thorén P, Asberg M, Cronholm B, Jörnestedt L, Träskman L.

Arch Gen Psychiatry. 1980 Nov;37(11):1281-5.

PMID:
7436690
18.

Long-term follow-up study of patients with refractory obsessive-compulsive disorder.

Ross S, Fallon BA, Petkova E, Feinstein S, Liebowitz MR.

J Neuropsychiatry Clin Neurosci. 2008 Fall;20(4):450-7. doi: 10.1176/appi.neuropsych.20.4.450.

PMID:
19196930
19.

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).

Haghighi M, Jahangard L, Mohammad-Beigi H, Bajoghli H, Hafezian H, Rahimi A, Afshar H, Holsboer-Trachsler E, Brand S.

Psychopharmacology (Berl). 2013 Aug;228(4):633-40. doi: 10.1007/s00213-013-3067-z. Epub 2013 Mar 23.

PMID:
23525525
20.

Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.

Sevincok L, Topuz A.

J Clin Psychopharmacol. 2003 Oct;23(5):448-50.

PMID:
14520120
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk